Study of FOXO1/pFOXO1, lncRNA ADAMTS9-AS2, and miR-96-5p in laryngeal squamous cell carcinoma
Masoomeh Bakhshandeh, Payam Mohammadi, Najmeh Parvaz, Maryam Lotfi, Omid Joodi, Mohammad Najafi · 2025
Read Study of FOXO1/pFOXO1, lncRNA ADAMTS9-AS2, and miR-96-5p in laryngeal squamous cell carcinoma by Masoomeh Bakhshandeh, Payam Mohammadi, Najmeh Parvaz, Maryam Lotfi, Omid Joodi, Mohammad Najafi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729057.txt.
Description
Masoomeh Bakhshandeh and co-authors present a 2025 study of a gene network in throat cancer, the second most common cancer of the breathing tract. They focused on a gene called FOXO1 and two short RNA strands that interact with it. Tissue came from fifty patients having surgery for the cancer. Each cancer sample was paired with normal tissue from the same person. Lab tests measured gene and protein levels in both kinds of sample. Public cancer data added survival checks.
Levels of FOXO1 and its partner long RNA were lower in the cancer tissue. The short RNA strand, by contrast, ran higher in the tumors. Protein levels for FOXO1 and its changed form were also reduced. Patients with higher FOXO1 or partner RNA levels lived longer on average. The authors suggest the two act to hold tumor growth back. The short RNA, they say, may help drive the cancer instead.
Catalog record
| CREATOR | Masoomeh Bakhshandeh, Payam Mohammadi, Najmeh Parvaz, Maryam Lotfi, Omid Joodi, Mohammad Najafi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |